Results of using the neuroprotective drug Cellex in non-traumatic intracranial hemorrhage
Introduction. In the Russian Federation, neuroprotective agents are widely used in the treatment of patients with ischemic stroke. There are accumulated data on the efficacy and safety of the neuroprotective agent Cellex® in ischemic stroke. The use of this drug in hemorrhagic stroke has been studie...
Principais autores: | Kh. D. Mongush, A. V. Kyrgys, A. A. Sedip, A. E. Shyyrap, A. B. Ondar, M. G. Zhestikova |
---|---|
Formato: | Artigo |
Idioma: | Russian |
Publicado em: |
Remedium Group LLC
2022-03-01
|
coleção: | Медицинский совет |
Assuntos: | |
Acesso em linha: | https://www.med-sovet.pro/jour/article/view/6755 |
Registros relacionados
-
Efficacy of Cellex in patients with mild cognitive impairment
por: B. A. Abusueva, et al.
Publicado em: (2019-04-01) -
NEUROPROTECTION INFLUENCE ON COURSE OF CEREBRAL STROKE
por: G. N. BELSKAYA, et al.
Publicado em: (2016-12-01) -
Neuroprotection by Ozanimod Following Intracerebral Hemorrhage in Mice
por: Fei Wang, et al.
Publicado em: (2022-06-01) -
Drug-induced non-traumatic intracranial hemorrhage associated with the use of anticoagulants and antiplatelet agents
por: O. D. Ostroumova, et al.
Publicado em: (2022-12-01) -
Acute albumin administration as therapy for intracerebral hemorrhage: A literature review
por: Yirong Cao, et al.
Publicado em: (2024-01-01)